---
title: "Pharmacy Chains Industry: Companies"
description: "3 SEC filers are classified under the Standard Industrial Classification code that describes the pharmacy chains industry."
canonical: https://www.getswoopr.com/stocks/industries/consumer-staples/pharmacy-chains/
source: "Swoopr Investment: https://www.getswoopr.com"
---

# Pharmacy Chains Industry

## Direct Answer

3 SEC filers are classified under the Standard Industrial Classification code that describes the pharmacy chains industry, and their latest annual reports show $403.7 billion of combined revenue and a median operating margin of 1.2%. Investors should still evaluate its revenue model, industry-specific KPIs, valuation framework and the risks that can change the group's economics.

## Industry Overview

Pharmacy chains operate retail pharmacies that fill prescriptions and sell health and wellness products, earning margins on drugs set by payers and pharmacy benefit managers. Reimbursement pressure and store closures are shaping the sector. The first numbers to compare across companies here are prescription count and growth, pharmacy gross margin and front-store sales.

## Key Industry Metrics

- **Prescription count and growth**: The number of prescriptions filled and its change over time. Rising counts show demand and customer traffic, though each one earns little after reimbursement.
- **Pharmacy gross margin**: Profit left after drug cost on prescriptions. It depends on rates set by insurers and benefit managers, so it can fall even when counts rise.
- **Front-store sales**: Sales of non-prescription goods such as health, beauty and groceries. These earn higher margins than prescriptions, so weak front-store sales weigh on profit.
- **Store count**: The number of pharmacies open. Closures of weak sites can improve average results but shrink total reach and revenue.
- **Operating margin**: Profit after store, labor and overhead costs as a share of sales. It is thin and sensitive to reimbursement and wage trends.

## Primary Macro Drivers

- **Reimbursement rates**: Payers and benefit managers set what pharmacies are paid per prescription, so lower rates cut pharmacy gross margin directly.
- **Generic drug mix**: Generics carry lower sales but often higher percentage margins, so changes in mix move pharmacy margin and revenue.
- **Health services expansion**: Clinics, vaccines and testing add revenue beyond dispensing, shown in front-store and pharmacy same-store sales and margin.
- **Competition from mail order and online**: Mail-order and online pharmacies take prescriptions, so look at prescription count and growth for signs of share loss.

## Major Risks

- **Payer reimbursement pressure**: Falling per-prescription payments can outpace volume gains, so watch pharmacy gross margin against prescription count.
- **Store closures**: Closing weak sites cuts sales and triggers lease and restructuring costs, visible in store counts and charges.
- **Competition from online**: Digital and mail pharmacies and mass retailers take scripts and shoppers, so look at prescription volume and front-store sales.
- **Litigation such as opioid claims**: Large legal claims create accruals and cash payments over years, so read the legal contingency notes for exposure.

## Industry Characteristics

| Characteristic | Profile |
| --- | --- |
| Cyclicality | Defensive |
| Capital Intensity | Medium |
| Regulatory Intensity | High |
| Industry Maturity | Mature |
| Geographic Importance | U.S. |

## Pharmacy Chains Filers in the SEC Record

3 companies with annual reports in the dataset are classified by the SEC in the Standard Industrial Classification code 5912. Their latest fiscal years end between 2025 and 2026, and together they reported $403.7 billion of revenue. Median revenue growth over the prior year was 7.8%. Median operating margin was 1.2% and median net margin 0.4%. Median total liabilities were 64% of total assets, and 2 of 3 reported a profit in their latest year.

| Company | Revenue | Growth | Operating margin | Net margin | Year |
| --- | --- | --- | --- | --- | --- |
| [Cvs Health Corp](https://www.getswoopr.com/stocks/companies/cvs-health/) | $402.1 billion | 7.8% | 1.2% | 0.4% | FY 2025 |
| [Guardian Pharmacy Services, Inc.](https://www.getswoopr.com/stocks/companies/guardian-pharmacy-services-inc/) | $1.4 billion | 17.9% | 5.0% | 3.4% | FY 2025 |
| [Petmed Express Inc](https://www.getswoopr.com/stocks/companies/petmed-express-inc/) | $179 million | -21.1% | -32.8% | -32.0% | FY 2026 |

Source: each company's own annual report as filed with the SEC (XBRL data), figures in U.S. dollars. A company's SIC code reflects its main business as the SEC records it, so it can differ from how an index provider or analyst classifies the company, and a diversified group appears under only one code.

## Where to Go Next

The Pharmacy Chains guide describes how the industry earns money, what to measure and what can go wrong. To see how it compares, read the neighbouring industries in the same sector, then apply the same checks to a specific company.

### More in Consumer Staples

- [Consumer Staples sector overview](https://www.getswoopr.com/stocks/industries/consumer-staples/)
- [Plant-Based Foods](https://www.getswoopr.com/stocks/industries/consumer-staples/plant-based-foods/)
- [Personal Hygiene](https://www.getswoopr.com/stocks/industries/consumer-staples/personal-hygiene/)
- [Seafood Processing](https://www.getswoopr.com/stocks/industries/consumer-staples/seafood-processing/)
- [Personal Care Products](https://www.getswoopr.com/stocks/industries/consumer-staples/personal-care-products/)
- [Skin Care](https://www.getswoopr.com/stocks/industries/consumer-staples/skin-care/)
- [Paper Household Products](https://www.getswoopr.com/stocks/industries/consumer-staples/paper-household-products/)
- [Smokeless Tobacco](https://www.getswoopr.com/stocks/industries/consumer-staples/smokeless-tobacco/)
- [Packaged Foods](https://www.getswoopr.com/stocks/industries/consumer-staples/packaged-foods/)

### Put it to work

- [How to analyze a stock](https://www.getswoopr.com/stocks/how-to-analyze-a-stock/)
- [Fundamental analysis guides](https://www.getswoopr.com/learn/fundamental-analysis/)
- [Company research](https://www.getswoopr.com/stocks/companies/)
- [All industries](https://www.getswoopr.com/stocks/industries/)

## Frequently Asked Questions

What are the main KPIs for the Pharmacy Chains industry?

Key performance indicators for the Pharmacy Chains industry include: Prescription count and growth, Pharmacy gross margin, Front-store sales, Store count, Operating margin. Which matter most depends on the company's model, so compare them across several companies rather than relying on one.

How cyclical is the Pharmacy Chains industry?

The Pharmacy Chains industry is generally defensive, meaning demand tends to remain relatively stable regardless of the economic cycle. Companies in this space can provide portfolio stability during recessions, though growth may lag in strong expansions.

What are the biggest risks in the Pharmacy Chains industry?

The primary risks for Pharmacy Chains companies include: Payer reimbursement pressure, Store closures, Competition from online, Litigation such as opioid claims. Investors should assess each company's exposure to these factors and its track record of navigating them.

**[Swoopr Editorial Team](https://www.getswoopr.com/authors/swoopr-editorial-team/)**

Swoopr's editorial team produces independent investment education content reviewed for accuracy and clarity. We do not provide personalized financial advice. See our [editorial policy](https://www.getswoopr.com/legal/editorial-policy/) and [corrections policy](https://www.getswoopr.com/legal/corrections-policy/).
